Menu
Recruiting NCT07572942

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

Observational Motoric Cognitive Risk Syndrome Cognitive-Motor Interaction Sensorimotor Performance

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Motoric Cognitive Risk Syndrome, Cognitive-Motor Interaction, Sensorimotor Performance. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Validity and Reliability of Neuroscience-Based Visual Laser Feedback Map Tests in Individuals With Motoric Cognitive Risk Syndrome

Overview

This study aims to evaluate the validity and reliability of neuroscience-based visual laser feedback map tests in individuals with Motoric Cognitive Risk Syndrome (MCRS). The developed assessment protocol integrates visuospatial processing, reaction time, and upper extremity motor control within a single task. Construct validity will be examined through correlations with reaction time and proprioception measurements, and test-retest reliability will be assessed to determine measurement consistency.

Primary outcome measures

  • Visual-laser feedback map test performance [Time frame: Baseline]
Secondary outcome measures (4)
  • Reaction time [Time frame: Baseline]
  • Shoulder proprioception [Time frame: Baseline]
  • Test-retest reliability [Time frame: Baseline and 7-day follow-up]
  • Measurement error [Time frame: Baseline and 7-day follow-up]

Eligibility criteria

Inclusion criteria

Aged ≥65 years Diagnosis of Motoric Cognitive Risk Syndrome (subjective cognitive complaint + slow gait) Living independently in the community Able to understand and perform test procedures

Exclusion criteria

Diagnosed dementia Severe psychiatric disorders Advanced visual impairments (e.g., macular degeneration, severe cataract) Neurological disorders affecting motor control Severe tremor or ataxia interfering with task performance

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Turkey (Türkiye) · 1 center
  • Balikesir University — Balıkesir

Publications

  • Pinzón-Ríos, I. D., & Moreno-Collazos, J. E. (2020). Neural aging, brain plasticity and exercise: Advances from a physiotherapy perspective. Archivos de Medicina (Manizales), 20(1), 188-202.
  • Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31. PMID 27330520
  • Shadmehr R, Krakauer JW. A computational neuroanatomy for motor control. Exp Brain Res. 2008 Mar;185(3):359-81. doi: 10.1007/s00221-008-1280-5. Epub 2008 Feb 5. PMID 18251019
  • Moinuddin A, Goel A, Sethi Y. The Role of Augmented Feedback on Motor Learning: A Systematic Review. Cureus. 2021 Nov 18;13(11):e19695. doi: 10.7759/cureus.19695. eCollection 2021 Nov. PMID 34976475
  • Clark DJ. Automaticity of walking: functional significance, mechanisms, measurement and rehabilitation strategies. Front Hum Neurosci. 2015 May 5;9:246. doi: 10.3389/fnhum.2015.00246. eCollection 2015. PMID 25999838
  • Seidler RD, Bernard JA, Burutolu TB, Fling BW, Gordon MT, Gwin JT, Kwak Y, Lipps DB. Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci Biobehav Rev. 2010 Apr;34(5):721-33. doi: 10.1016/j.neubiorev.2009.10.005. Epub 2009 Oct 20. PMID 19850077

Identifiers

NCT: NCT07572942 · 2026/47

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗